drugset
drugset / Trial / NCT03913702

Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement

NCT03913702 ↗

Phase 2 Terminated 1 enrolled The University of Texas Medical Branch, Galveston
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators aim to compare subacromial ketorolac (non-steroidal anti-inflammatory drug) versus methylprednisolone (steroid) for the treatment of shoulder impingement syndrome.

Timeline

Start
2019-09-09
Primary completion
2022-11-02
Completion
2022-11-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 60 mg Other
Comparator Methylprednisolone Other / unclassified 80 mg Other

Indications

shoulder impingement syndrome